α-Arrestin ARRDC3 tumor suppressor function is linked to GPCR-induced TAZ activation and breast cancer metastasis
Aleena Arakaki(University of California San Diego), JoAnn Trejo(University of California, San Diego)
Cited by 30
Related Papers
G protein–coupled receptors activate p38 MAPK via a non-canonical TAB1–TAB2– and TAB1–TAB3–dependent pathway in endothelial cells
|Journal of Biological Chemistry|2019|47
Recycling and Endosomal Sorting of Protease-activated Receptor-1 Is Distinctly Regulated by Rab11A and Rab11B Proteins
|Journal of Biological Chemistry|2015|41
Characterization of Thrombin-Bound Dabigatran Effects on Protease-Activated Receptor-1 Expression and Signaling In Vitro
|Molecular Pharmacology|2015|31
Divergent regulation of α-arrestin ARRDC3 function by ubiquitination
|Molecular Biology of the Cell|2023|8
An siRNA library screen identifies CYLD and USP34 as deubiquitinases that regulate GPCR-p38 MAPK signaling and distinct inflammatory responses
|Journal of Biological Chemistry|2023|8